At 4 weeks post injury, in the ipsilateral DRG both DNMT1 and DNMT3a transcripts still showed a trend for a slight increase relative to sham controls (28% for DNMT1, p = 0.09, 42% for DNMT3a, p = 0.22); no significant increase was found in the DRG contralateral to nerve injury ( Figure 4C ).
Similarly female cKO animals showed a trend of higher latency to reach hidden platform on day 4 and 5 ( p = 0.09).
Overall sham mouse transitions showed a trend toward varying with dpo ( F (1.5,8.8) = 3.5, p = 0.09, one-way RM ANOVA).
On multivariable analysis, none of the variables was significant, with platelets count at last follow up showed a trend towards statistical significance (OR 0.95; CI 0.90–1.00; P = .09) (Table S7, http://links.lww.com/MD/H621 ). 4.
Correlations between fPDRP NS expression and motor ratings were also significant in the North Shore PD sample (r = 0.61, p < 0.01; Pearson correlation) and showed a trend in the Cologne dataset (r = 0.24, p = 0.09). 3.2.
The analysis also showed a trend toward a possible association between persistent headache and depressive symptoms (univariate analysis with an OR of 8.000 [range: 0.725–88.226]; p = 0.090).
Although TNM7 stage I showed a trend toward reduced recurrence risk (HR = 0.472; 95% CI: 0.198–1.123; p = 0.090), this association did not reach statistical significance.
The regression model for NSE [R 2 = 0.03, F (3, 234) = 2.65, p = 0.05] revealed a significant effect for group, i.e., increased values in mild NCD compared to healthy controls (β = 0.29, t (230) = −1.75, p = 0.04), whereas age (β = −0.0006, t (230) = −0.39, p = 0.69) was not significant and interaction showed a trend (β = 0.004, t (230) = 1.67, p = 0.09).
However, the triangular index showed a trend toward lower values in patients of Group 3 ( p = 0.09).
For Model 2 a sensitivity analysis of biopsy type (Table 3 ) showed that first TCMR on a for‐cause biopsy was a significant correlate of death‐censored and all‐cause graft loss, while first TCMR on a surveillance biopsy showed a trend ( p = .09) toward an increased risk of death‐censored allograft loss and no significant association with all‐cause allograft loss after adjustment for baseline covariates, DGF, and ABMR.
Atf4 overexpression increased Atf4 mRNA levels compared to control-transfected cells ( Figure 4K ) and showed a trend towards increasing survival of detached non-metastatic cells ( Figure 4L , 8%, P =0.09).
Vice versa, patients with AF recurrence showed a trend towards a higher median AHI value, 14.7 (IQR, 7.5–28.0) versus 10.6 (IQR, 6.6–16.5), P = 0.09 ( Fig. 3 ).
Patients with cutaneous manifestations showed a trend towards lower frequency of lung damage ( p = 0.09).
At 16 and 24 weeks, O-CAF rats also showed a trend to greater fat mass than O-C rats ( p = 0.09, two-way ANOVA), but no significant differences were found between both groups.
The intervention also showed a trend toward statistical significance in abstinence knowledge scores (0.129, P =.09).
1.4 months, HR 0.37, one-sided p < 0.0001) and updated analysis showed a trend towards better median OS in the experimental arm (10.3 vs. 7.5 months, HR 0.79, p = 0.09), which may have been impacted by crossover from the placebo to treatment group [ 10 , 38 ].
22-26 Furthermore, mutational profiling of pretreatment biopsy samples with matched gene expression data showed a trend toward more non-CR patients in the TP53 mutant group ( P = .09) ( Figure 6G ).
In the univariate analysis, high METTL5 expression showed a trend towards poor prognosis (HR = 1.54, 95% CI 0.94–2.55, P = 0.09).
The subsequent day showed a trend, albeit not statistically significant, towards the same trajectory of urine calcium dynamics (day 5, 1.40 vs 1.66; P = 0.09).
1 E) showed a trend of higher activity, by 150% in the cells isolated with TrypLE in comparison to keratinocytes isolated by trypsin ( p -value = 0.09).
1.4, p = 0.014) and the frequency of CD34 + CD38 + cells (gate P-5) also showed a trend of increase (15.31 vs. 12.74, trend: p = 0.09) in LJP-1586 treated mice (Fig. 5 b, c).
While serum cytokine profiles showed largely similar increases between PBS-CpG and CpG-CpG ( Figure 7D ), serum IL-18 levels showed a trend toward increased levels in mice with recurrent MAS ( P = 0.09), in agreement with elevated IL-18 in patients with a history of MAS ( 26 ).
Patients in the acute stage showed a trend towards elevated T2 values (p = 0.09), and had the highest T2 values (58 and 60 ms, respectively).
The Zargar classification showed a trend towards more gastric injury in the COVID-19 vs pre-COVID-19 periods: 8/17 vs 1/9 (p=0.09).
Among ever users of HRT (n=61), the duration of use (>9 years) showed a trend for association with EC risk (HR 2.03 (95% CI 0.89–4.62), P =0.09).